U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. PANZYGA
  1. Approved Blood Products

STN: 125587
Proper Name: Immune Globulin Intravenous (Human)-ifas
Tradename: PANZYGA
Manufacturer: Octapharma Pharmazeutika Produktionsges.m.b.HIndication
Indication:

  • for the treatment of adults 18 years of age and older with chronic inflammatory demyelinating polyneuropathy (CIDP) to improve neuromuscular disability and impairment.
  • Primary humoral immunodeficiency (PI) in patients 2 years of age and older.
  • Chronic immune thrombocytopenia (ITP) in adults.

Product Information

Supporting Documents

Back to Top